(Q46473099)

22 December 2017

title

Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome (English)

1 reference

22 December 2017

polycystic ovary syndrome

0 references

1 reference

1 reference

1 reference

M I Ahmed

1

1 reference

22 December 2017

A J Duleba

2

1 reference

22 December 2017

O El Shahat

3

1 reference

22 December 2017

M E Ibrahim

4

1 reference

22 December 2017

A Salem

5

1 reference

22 December 2017

language of work or name

English

0 references

publication date

18 July 2008

1 reference

22 December 2017

published in

Human Reproduction

1 reference

22 December 2017

volume

23

1 reference

22 December 2017

issue

11

1 reference

22 December 2017

page(s)

2564-2569

1 reference

22 December 2017

The prevalence and features of the polycystic ovary syndrome in an unselected population

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Passive smoking affects endothelium and platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Role of opioid antagonists in the treatment of women with glucoregulation abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Opioid modulation of taste responses in the nucleus of the solitary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Relationship between persistence of abdominal symptoms and successful outcome after cholecystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Obesity and reproduction: impact and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN273

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DEN273

1 reference

22 December 2017

PubMed ID

18641399

1 reference

22 December 2017